Videocolonoscope CF-Q180AI

Hospital Endoscopy Departments

Hospital endoscopy units are under increasing quality pressure to improve adenoma detection rates and maintain consistent colonoscopy performance across high-volume procedure lists. The CF-Q180AI's AI-assisted detection capability provides real-time support to endoscopists during withdrawal, assisting in the identification of polyps that might otherwise be missed. Combined with high-definition NBI imaging, the CF-Q180AI helps endoscopy departments meet and maintain colonoscopy quality indicator benchmarks including adenoma detection rate and withdrawal time standards.

Colorectal Cancer Screening Programmes

Population-based colorectal cancer screening depends on reliable, consistent polyp detection across diverse endoscopists and patient complexity levels. The CF-Q180AI's AI-assisted computer-aided detection technology supports consistent detection performance regardless of individual endoscopist variability, while NBI enhances visibility of flat and diminutive lesions. These capabilities support screening programmes in achieving adenoma detection rate targets and reducing miss rates across high-volume screening lists.

Specialist Gastroenterology and IBD Surveillance

Gastroenterology units performing IBD surveillance colonoscopy require detailed mucosal assessment to identify dysplasia at the earliest possible stage. The CF-Q180AI's NBI technology enables precise evaluation of mucosal vascular patterns and surface architecture to guide targeted biopsy. Its AI-assisted detection adds an additional layer of lesion identification support during IBD surveillance, where dysplastic change may present with subtle or atypical mucosal appearances.

Therapeutic and Interventional Endoscopy Units

Endoscopists performing polypectomy, endoscopic mucosal resection, and haemostatic intervention require clear mucosal visualisation combined with reliable therapeutic access. The CF-Q180AI's large working channel accommodates full-size therapeutic accessories, while HD imaging and NBI support confident lesion margin assessment before and during endoscopic therapeutic procedures.

For Hospitals and Endoscopy Departments

The CF-Q180AI integrates with Olympus EVIS EXERA III systems and is compatible with EMR, PACS, and endoscopy reporting platforms, supporting the digital workflow and audit requirements of accredited endoscopy departments. AI-assisted detection capability supports compliance with adenoma detection rate quality indicators monitored by endoscopy accreditation programmes. CE certification and full technical documentation satisfy hospital procurement and government tender requirements. Medigear.uk provides institutional buyers with procurement support, compliance documentation, and after-sales service coordination.

For Clinics, Diagnostic Centres, and Specialist Units

The CF-Q180AI delivers hospital-grade AI-assisted HD colonoscopy with NBI in a clinical package appropriate for specialist gastroenterology clinics and private endoscopy centres. AI-assisted detection supports premium diagnostic performance across varied case complexity and endoscopist experience levels. The scope's compatibility with Olympus EVIS EXERA III platforms already deployed in many endoscopy units simplifies integration and reduces infrastructure requirements for upgrading facilities.

For Medical Equipment Distributors

The CF-Q180AI represents a high-value position in the Olympus colonoscopy portfolio, combining AI-assisted detection with high-definition NBI imaging ,two of the most in-demand clinical capabilities in the current endoscopy market. Medigear.uk supports authorised distributors with full product documentation, technical training, and warranty and service infrastructure. AI-assisted colonoscopy represents a growing and strategically important distribution category with strong procurement demand across hospital, screening, and specialist markets.

AI-Assisted Computer-Aided Polyp Detection

The CF-Q180AI is compatible with Olympus AI-assisted detection platforms providing real-time computer-aided polyp detection during colonoscopy withdrawal. This assists endoscopists in identifying diminutive, flat, and subtle lesions, supporting reduced adenoma miss rates and more consistent detection across varied clinical volumes.

High-Definition EVIS EXERA III Imaging

The scope delivers high-definition colonoscopy imaging through the Olympus EVIS EXERA III platform, providing exceptional mucosal clarity and colour fidelity during diagnostic and therapeutic procedures. HD visualisation supports accurate lesion identification and clinical decision-making throughout the examination.

Narrow Band Imaging for Mucosal Enhancement

NBI selectively illuminates mucosal vasculature and surface microstructure without chemical dye, enhancing visibility of polyps, vascular patterns, and lesion margins during live colonoscopy. Activated at the touch of a button, NBI supports real-time differentiation of adenomatous and non-neoplastic lesions.

Wide-Angle Field of View

An expanded field of view reduces mucosal blind spots behind haustral folds, supporting comprehensive colorectal surveillance during withdrawal. This is particularly valuable during screening, IBD surveillance, and diagnostic colonoscopy in varied patient anatomy.

Large Working Channel for Therapeutic Flexibility

The generous working channel accommodates biopsy forceps, polypectomy snares, haemostatic clips, and injection needles, enabling combined diagnostic and therapeutic colonoscopy within a single session.

CE Certified with EMR and PACS Integration

The CF-Q180AI carries CE certification and integrates with EVIS EXERA III processors, EMR, PACS, and endoscopy reporting platforms for direct procedure data transfer into the patient record and department management system.

The CF-Q180AI videocolonoscope delivers a powerful combination of AI-assisted computer-aided polyp detection, high-definition NBI optical imaging, and seamless digital connectivity in one clinically trusted Olympus instrument. Hospitals and endoscopy departments benefit from improved adenoma detection rates, consistent performance across varied procedure volumes, and structured digital workflow integration. Specialist gastroenterology and IBD surveillance units value the precision that NBI and AI-assisted detection together provide for detailed mucosal assessment. Distributors recognise the CF-Q180AI as a flagship Olympus endoscopy product with strong and growing procurement demand across hospital, screening, and specialist clinical markets. Whether equipping a new endoscopy unit, upgrading an existing colonoscopy programme, or supplying a specialist gastroenterology centre, the CF-Q180AI delivers intelligent imaging and clinical confidence at every level. Contact Medigear.uk for product specifications, procurement assistance, or expert consultation.